Unhealthy Lifestyle Choices and Disturbed Work Life Balance to Lead Increased Sales of Antihypertensive Drugs Market; Valuation to Rise Up to US$33.9 Bn by 2027, Finds TMR

Unhealthy Lifestyle Choices and Disturbed Work Life Balance to Lead Increased Sales of Antihypertensive Drugs Market; Valuation to Rise Up to US$33.9 Bn by 2027, Finds TMR

PR Newswire

ALBANY, New York, March 11, 2020

Naturally, there is huge demand for antihypertensive drugs as people struggle to move out of their busy lifestyles and unhealthy eating and living habits

ALBANY, New York, March 11, 2020 /PRNewswire/ -- Events and developments that are shaping the growth curve of the global antihypertensive drugs market are being closely monitored by Transparency Market Research. TMR has recently published a new research about the market and provides an in-depth information about the inner working dynamics of the global antihypertensive drugs market. According to the research report, the global market will exhibit a modest CAGR of ~2% over the course of the forecast period ranging from 2019 to 2027. The market was initially valued at US$27.8 bn in 2018. With the given rate of growth, the valuation of the market will rise up to around US$33.9 Bn by the end of 2027.

Transparency Market Research Logo

"In the last few decades, a considerable amount of research has been done for the development of new therapeutics and effective antihypertensive drugs. In spite of considerable developments in genomics and their clinical applications, landmark developments in the global antihypertensive drugs market are still achieved slowly. Drug manufacturers are continually investing huge resources in the development and discovery of hugely popular drugs. However, in order to reach the goal, the key stakeholders in the present market for antihypertensive drugs are expected to adopt a multi-sector approach that will concentrate on various aspects such as population sciences, digital, and data among others", observes TMR analyst.

Request PDF Brochure of Antihypertensive Drugs Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7718

Key Findings in the Research Report: 

Explore a 213 pages report with detailed research, incisive insights, and in-depth country levels estimations. Gain business intelligence on global Antihypertensive Drugs Market by Drug: Diuretics, Angiotensin Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, Beta-blockers, Vasodilators, Calcium Channel Blockers, Renin Inhibitors, Alpha-blockers, and Others; Condition: Primary Hypertension and Secondary Hypertension; Medication Type: Monotherapy, Combination Therapy, and Fixed Dose Combinations; and Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Others, Read Details TOC of the Report - https://www.transparencymarketresearch.com/report-toc/7718

Global Antihypertensive Drugs Market – Key Driving Factors

Global Antihypertensive Drugs Market – Geographical Outlook

Analyze Antihypertensive Drugs market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea. Request a sample of the study.

Global Antihypertensive Drugs Market – Key Market Players

Some of the prominent names in the global antihypertensive drugs market include names such as Pfizer, Inc., Sanofi S.A., Novartis AG, AstraZeneca plc, and Boehringer Ingelheim GmbH.

Global Antihypertensive Drugs Market: Segmentation

Antihypertensive Drugs Market, by Drug

Antihypertensive Drugs Market, by Condition

Antihypertensive Drugs Market, by Medication Type

Antihypertensive Drugs Market, by Distribution Channel

Antihypertensive Drugs Market, by Region

Explore Transparency Market Research's award-winning coverage of the Global Pharmaceutical Industry:

Prescription Dermatology Therapeutics Market: The global prescription dermatology therapeutics market is growing at a rapid pace due to high prevalence and increase in incidence rate of chronic and infectious dermatological disorders, and new product development and commercialization across the globe. In terms of revenue, the global market was valued at US$ 27,580.0 Mn in 2017 and is projected to reach US$ 61,296.1 Mn by 2026, expanding at a CAGR of 9.5% from 2018 to 2026.

Head and Neck Cancer Market: According to the report, the global head and neck cancer market was valued at US$ 933.3 Mn in 2017 and is anticipated expand at a CAGR of 9.2% from 2018 to 2026. Growth of the pharmaceutical industry, government initiatives, increase in health care expenditure, surge in product approval, and rise in patient population are projected to augment the global market from 2018 to 2026.

Intravenous Immunoglobulin Market: The global intravenous immunoglobulin market continues to expand at a high growth rate. The market is driven by rise in global prevalence of autoimmune diseases such as primary humoral immunodeficiency (PIDD), multiple sclerosis, immune thrombocytopenia purpura (ITP), autoimmune hemolytic anemia, and Kawasaki syndrome.

Oral Anticoagulant Market: A major factor expected to drive the global oral anticoagulant market is rise in the adoption of drugs, particularly among geriatric patients, who are at a higher risk of heart attacks and strokes. Moreover, factors such as rapid onset of action, short half-life, and little or no food interaction are likely to boost the market.

Gain access to Market Ngage, an AI-powered, real-time business intelligence that goes beyond the archaic research solutions to solve the complex strategy challenges that organizations face today. With over 15,000+ global and country-wise reports across 50,000+ application areas, Market Ngage is your tool for research on-the-go. From tracking new investment avenues to keeping a track of your competitor's moves, Market Ngage provides you with all the essential information to up your strategic game. Power your business with Market Ngage's actionable insights and remove the guesswork in making colossal decisions.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com 
Website: http://www.transparencymarketresearch.com 

Logo: https://mma.prnewswire.com/media/1085206/Transparency_Market_Research_Logo.jpg

Voltar noticias em Inglês